These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11924833)

  • 21. Histological and immunocytochemical studies of human psoriatic lesions transplanted onto SCID mice.
    Sugai J; Iizuka M; Kawakubo Y; Ozawa A; Ohkido M; Ueyama Y; Tamaoki N; Inokuchi S; Shimamura K
    J Dermatol Sci; 1998 Jun; 17(2):85-92. PubMed ID: 9673889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of disease by superantigens.
    Torres BA; Johnson HM
    Curr Opin Immunol; 1998 Aug; 10(4):465-70. PubMed ID: 9722924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding the mechanism of action of bacterial superantigens from a decade of research.
    Lavoie PM; Thibodeau J; Erard F; Sékaly RP
    Immunol Rev; 1999 Apr; 168():257-69. PubMed ID: 10399079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating the role of HLA-DQ polymorphisms on immune response to bacterial superantigens using transgenic mice.
    Rajagopalan G; Polich G; Sen MM; Singh M; Epstein BE; Lytle AK; Rouse MS; Patel R; David CS
    Tissue Antigens; 2008 Feb; 71(2):135-45. PubMed ID: 18086265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor response elicited by a superantigen-transmembrane sequence fusion protein anchored onto tumor cells.
    Wahlsten JL; Mills CD; Ramakrishnan S
    J Immunol; 1998 Dec; 161(12):6761-7. PubMed ID: 9862706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of bacterial superantigens in pathophysiology of the skin].
    Boehncke WH; Zollner TM
    Hautarzt; 1999 Feb; 50(2):91-7. PubMed ID: 10097950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical analysis of staphylococcal superantigen hyper-reactive patients with psoriasis vulgaris.
    Yamamoto T; Katayama I; Nishioka K
    Eur J Dermatol; 1998; 8(5):325-9. PubMed ID: 9683864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidermal HLA-DR and the enhancement of cutaneous reactivity to superantigenic toxins in psoriasis.
    Travers JB; Hamid QA; Norris DA; Kuhn C; Giorno RC; Schlievert PM; Farmer ER; Leung DY
    J Clin Invest; 1999 Nov; 104(9):1181-9. PubMed ID: 10545517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha.
    Boyman O; Hefti HP; Conrad C; Nickoloff BJ; Suter M; Nestle FO
    J Exp Med; 2004 Mar; 199(5):731-6. PubMed ID: 14981113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential presentation of group A streptococcal superantigens by HLA class II DQ and DR alleles.
    Norrby-Teglund A; Nepom GT; Kotb M
    Eur J Immunol; 2002 Sep; 32(9):2570-7. PubMed ID: 12207341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1alpha,25-dihydroxycholecalciferol and cyclosporine suppress induction and promote resolution of psoriasis in human skin grafts transplanted on to SCID mice.
    Dam TN; Kang S; Nickoloff BJ; Voorhees JJ
    J Invest Dermatol; 1999 Dec; 113(6):1082-9. PubMed ID: 10594756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Viral superantigens].
    Lafon M
    Rev Med Interne; 2000 Aug; 21(8):713-6. PubMed ID: 10989504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Superantigens, autoantigens, and pathogenic T cells in psoriasis.
    Nickoloff BJ; Wrone-Smith T
    J Invest Dermatol; 1998 Apr; 110(4):459-60. PubMed ID: 9540994
    [No Abstract]   [Full Text] [Related]  

  • 34. The search for pathogenic T cells and the genetic basis of psoriasis using a severe combined immunodeficient mouse model.
    Nickoloff BJ
    Cutis; 2000 Feb; 65(2):110-4. PubMed ID: 10696565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacterial superantigens in human disease: structure, function and diversity.
    Ulrich RG; Bavari S; Olson MA
    Trends Microbiol; 1995 Dec; 3(12):463-8. PubMed ID: 8800837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model.
    Sano S; Chan KS; Carbajal S; Clifford J; Peavey M; Kiguchi K; Itami S; Nickoloff BJ; DiGiovanni J
    Nat Med; 2005 Jan; 11(1):43-9. PubMed ID: 15592573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preservation of the specificity of superantigen to T cell receptor V beta elements in the absence of MHC class II molecules.
    Kotb M; Watanabe-Ohnishi R; Aelion J; Tanaka T; Geller AM; Ohnishi H
    Cell Immunol; 1993 Dec; 152(2):348-57. PubMed ID: 8258143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Animal models of psoriasis.
    Boehncke WH; Schön MP
    Clin Dermatol; 2007; 25(6):596-605. PubMed ID: 18021898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunopathogenesis of psoriasis: news in an old concept.
    Guilhou J
    Dermatology; 1998; 197(4):310-2. PubMed ID: 9873165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-DO increases bacterial superantigen binding to human MHC molecules by inhibiting dissociation of class II-associated invariant chain peptides.
    Pezeshki AM; Azar GA; Mourad W; Routy JP; Boulassel MR; Denzin LK; Thibodeau J
    Hum Immunol; 2013 Oct; 74(10):1280-7. PubMed ID: 23756162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.